Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -263.41%-1.92M | 14.65%-1.42M | -379.47%-2.23M | 31.32%-4.74M | -9.14%-2.08M | 36.22%-529.67K | 73.24%-1.66M | -122.61%-464.73K | 31.74%-6.9M | 58.25%-1.91M |
| Net income from continuing operations | -3,212.89%-2.99M | -567.99%-3.05M | 22.56%-1.17M | 128.61%6.23M | 224.05%6.99M | 105.20%96K | 105.90%650.77K | 53.84%-1.5M | 12.21%-21.77M | 44.76%-5.63M |
| Operating gains losses | -166.23%-27.27K | -1,023.06%-6.96K | -109,551.84%-1.88M | -527.31%-335.1K | -57,103.35%-373.94K | -17.13%41.18K | -102.24%-620 | -586.08%-1.71K | 182.79%78.42K | -99.14%656 |
| Depreciation and amortization | 700.64%121.62K | 532.89%124.93K | 420.02%131.04K | -87.65%112.76K | -72.59%52.63K | -92.40%15.19K | -92.40%19.74K | -90.36%25.2K | -23.28%913.02K | -37.73%192.01K |
| Asset impairment expenditure | ---1.43K | ---- | ---- | --306.61K | --306.61K | --0 | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | --0 | ---- | ---- | -198.62%-12.57M | -316.38%-8.61M | -11,110.44%-1.46M | ---- | ---- | 2,416.97%12.75M | 685.19%3.98M |
| Unrealized gains and losses of investment securities | 170.32%70.55K | 16.68%84.14K | -39.17%92.43K | 209.42%133.75K | 119.89%10.01K | -182.88%-100.32K | 279.63%72.11K | 3,989.10%151.95K | 50.56%-122.23K | -211.52%-50.34K |
| Remuneration paid in stock | 896.94%849.72K | 125.52%1.04M | 16,019.31%962.48K | 59.76%812.15K | 374.61%259.58K | -46.75%85.23K | 182.50%461.37K | -95.42%5.97K | -88.31%508.36K | 110.23%54.69K |
| Other non cashItems | 677.14%6.89K | --8.86K | --9.59K | -212.04%-466.68K | -102.45%-3.2K | -100.01%-1.19K | ---- | ---- | -9.42%416.53K | -34.33%130.87K |
| Change In working capital | -94.53%43.51K | 80.92%183K | -144.54%-382.41K | 218.05%1.04M | -23.18%-713.33K | 42.14%795.42K | 102.26%101.15K | -82.21%858.51K | 685.04%327.55K | 66.71%-579.11K |
| -Change in receivables | -82.76%-34.53K | -36.67%39.29K | -121.54%-50K | 104.74%263.4K | -104.42%-11.9K | -114.74%-18.89K | -86.46%62.03K | 131.94%232.16K | -35.52%128.65K | 9,665.98%269.09K |
| -Change in payables and accrued expense | -97.08%23.11K | 170.95%225.14K | -169.08%-404.96K | 447.58%859.14K | 29.84%-601.83K | 110.53%791.67K | 101.58%83.09K | -89.33%586.2K | 51.43%-247.17K | 63.95%-857.84K |
| -Change in other current assets | 142.63%54.93K | -85.17%-81.43K | 80.69%72.55K | -118.11%-80.79K | -1,133.20%-99.6K | -59.15%22.64K | -113.63%-43.98K | -31.01%40.15K | 47.73%446K | -97.19%9.64K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 100.12%67 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -263.41%-1.92M | 14.65%-1.42M | -379.47%-2.23M | 31.32%-4.74M | -9.14%-2.08M | -106.66%-529.67K | 88.91%-1.66M | -122.61%-464.73K | 31.74%-6.9M | 58.25%-1.91M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 654.40%658.1K | 7,901.71%27.31K | -99.42%835 | -97.71%4.64K | 234.53%625.32K | 98.54%-118.71K | 99.99%-350 |
| Net PPE purchase and sale | --0 | --0 | --0 | 654.40%658.1K | 7,901.71%27.31K | -99.42%835 | -97.71%4.64K | 234.53%625.32K | 98.14%-118.71K | 99.99%-350 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 654.40%658.1K | 7,901.71%27.31K | -99.42%835 | -97.71%4.64K | 234.53%625.32K | 98.54%-118.71K | 99.99%-350 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -56,351.18%-119.11K | -106.20%-120.31K | 37.45%-124.1K | 1,082.54%12.2M | 3,997.08%10.46M | 99.95%-211 | 686.16%1.94M | 13.41%-198.39K | -105.81%-1.24M | 83.51%-268.28K |
| Net issuance payments of debt | -56,351.18%-119.11K | 27.14%-120.31K | 37.45%-124.1K | 69.51%-405.46K | 88.30%-41.74K | 99.95%-211 | 50.12%-165.13K | 13.41%-198.39K | 74.91%-1.33M | -79.47%-356.85K |
| Net common stock issuance | --0 | ---- | ---- | --12.6M | --10.5M | --0 | ---- | ---- | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -96.91%88.57K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -56,351.18%-119.11K | -106.20%-120.31K | 37.45%-124.1K | 1,082.54%12.2M | 3,997.08%10.46M | 99.95%-211 | 686.16%1.94M | 13.41%-198.39K | -105.81%-1.24M | 83.51%-268.28K |
| Net cash flow | ||||||||||
| Beginning cash position | 173.64%6.08M | 307.11%7.87M | 428.15%10.23M | -81.09%1.94M | -60.09%1.68M | 162.69%2.22M | -83.33%1.93M | -81.09%1.94M | 64.63%10.24M | -77.87%4.21M |
| Current changes in cash | -286.35%-2.04M | -650.02%-1.54M | -6,124.07%-2.35M | 198.22%8.12M | 486.27%8.4M | -106.88%-529.04K | 101.85%280.23K | -102.78%-37.79K | -364.31%-8.26M | 76.76%-2.18M |
| Effect of exchange rate changes | 1,021.27%108.57K | -4,289.03%-256.7K | -112.82%-4.47K | 493.37%178.89K | 454.94%149.73K | -118.29%-11.79K | 109.58%6.13K | 1,019.49%34.82K | -105.08%-45.48K | -107.29%-42.18K |
| End cash Position | 146.52%4.14M | 173.64%6.08M | 307.11%7.87M | 428.15%10.23M | 428.15%10.23M | -60.09%1.68M | 162.69%2.22M | -83.33%1.93M | -81.09%1.94M | -81.09%1.94M |
| Free cash from | -263.41%-1.92M | 14.65%-1.42M | -379.47%-2.23M | 35.65%-4.74M | -9.07%-2.08M | -106.66%-529.67K | 88.90%-1.66M | -129.21%-464.73K | 59.63%-7.37M | 75.32%-1.91M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.